EVALI syndrome in a patient with hypersensitivity pneumonitis
- Authors: Asatryan A.O.1,2, Sinelnik E.A.1,2, Nedashkovskaya N.G.1,2, Kostryukov A.S.1, Barsukova N.A.1, Churyukina E.V.1,2,3
-
Affiliations:
- Rostov State Medical University
- Regional Clinical Hospital No. 2 of the Rostov Region
- Kuban State Medical University
- Issue: Vol 21, No 3 (2024)
- Pages: 426-435
- Section: Case reports
- Submitted: 13.06.2024
- Accepted: 31.07.2024
- Published: 24.10.2024
- URL: https://rusalljournal.ru/raj/article/view/16954
- DOI: https://doi.org/10.36691/RJA16954
- ID: 16954
Cite item
Abstract
Smoking electronic cigarettes, or vaping, is considered by many to be a safe alternative to smoking tobacco. It was only relatively recently that reports began to appear about the development of lung damage caused by electronic cigarettes ― EVALI syndrome. Currently, the morphological manifestations of this syndrome have not been studied sufficiently due to the small number of cases described in the literature. These facts, as well as the fact that the changes that occur are not specific, and may vary in different patients, make it difficult to diagnose the disease in a timely manner.
We have described a clinical case of death in a patient who has repeatedly received inpatient treatment for interstitial lung disease, who was admitted to the pulmonology department with signs of decompensated respiratory failure after prolonged and intensive use of electronic cigarettes. The autopsy revealed morphological signs and justified the clinical symptoms of chronic hypersensitive pneumonitis in combination with EVALI syndrome.
The article also provides a brief review of the literature on EVALI syndrome and hypersensitive pneumonitis with their diagnostic criteria. Like EVALI, hypersensitive pneumonitis is difficult to recognize and diagnose by doctors, which is often associated with low awareness, as well as the absence of pathognomonic symptoms.
Full Text
About the authors
Agunik O. Asatryan
Rostov State Medical University; Regional Clinical Hospital No. 2 of the Rostov Region
Author for correspondence.
Email: god2knows2@gmail.com
ORCID iD: 0009-0009-7294-4784
MD
Russian Federation, 29 Nachitsevanskij lane, 344022 Rostov-on-Don; Rostov-on-DonElena A. Sinelnik
Rostov State Medical University; Regional Clinical Hospital No. 2 of the Rostov Region
Email: 127pao.ob2@mail.ru
ORCID iD: 0000-0002-2201-5065
SPIN-code: 8996-5879
MD
Russian Federation, 29 Nachitsevanskij lane, 344022 Rostov-on-Don; Rostov-on-DonNatalia G. Nedashkovskaya
Rostov State Medical University; Regional Clinical Hospital No. 2 of the Rostov Region
Email: nenagen@mail.ru
ORCID iD: 0009-0002-6583-3241
MD
Russian Federation, 29 Nachitsevanskij lane, 344022 Rostov-on-Don; Rostov-on-DonArtyom S. Kostryukov
Rostov State Medical University
Email: artyomkostryukov@gmail.com
ORCID iD: 0009-0003-5477-858X
Russian Federation, 29 Nachitsevanskij lane, 344022 Rostov-on-Don
Nadezda A. Barsukova
Rostov State Medical University
Email: natalibarsukova@icloud.com
ORCID iD: 0009-0008-3744-2626
Russian Federation, 29 Nachitsevanskij lane, 344022 Rostov-on-Don
Ella V. Churyukina
Rostov State Medical University; Regional Clinical Hospital No. 2 of the Rostov Region; Kuban State Medical University
Email: echuryukina@mail.ru
ORCID iD: 0000-0001-6407-6117
SPIN-code: 8220-1439
MD
Russian Federation, 29 Nachitsevanskij lane, 344022 Rostov-on-Don; Rostov-on-Don; KrasnodarReferences
- Schier JG, Meiman JG, Layden J, et al. Severe pulmonary disease associated with electronic-cigarette-product use: Interim guidance. MMWR Morb Mortal Wkly Rep. 2019;68(36):787–790. doi: 10.15585/mmwr.mm6836e2
- Cecchini MJ, Mukhopadhyay S, Arrossi AV, et al. E-Cigarette or vaping product use-associated lung injury: A review for pathologists. Arch Pathol Lab Med. 2020;144(12):1490–1500. doi: 10.5858/arpa.2020-0024-RA
- Perrine CG, Pickens CM, Boehmer TK, et al. Characteristics of a multistate outbreak of lung injury associated with E-cigarette use, or vaping. MMWR. 2019;68(39):860–864. doi: 10.15585/mmwr.mm6839e1
- Winnicka L, Shenoy MA. EVALI and the pulmonary toxicity of electronic cigarettes: A review. J Gen Internal Med. 2020;35(7): 2130–2135. doi: 10.1007/s11606-020-05813-2
- Dicpinigaitis PV, Trachuk P, Fakier F, et al. Vaping-associated acute respiratory failure due to acute lipoid pneumonia. Lung. 2020;198(1):31–33. doi: 10.1007/s00408-019-00277-6
- Triantafyllou GA, Tiberio PJ, Zou RH, et al. Vaping-associated acute lung injury: A case series. Am J Respir Crit Care Med. 2019;200(11):1430–1431. doi: 10.1164/rccm.201909-1809LE
- Podzolkov VI, Vetluzhskaya MV, Abramova AA. Vaping and vaping-associated lung injury: A review. Ther Arch. 2023;95(7): 591–596. EDN: DZLOFU doi: 10.26442/00403660.2023.07.202293
- Wu D, O’Shea DF. Potential for release of pulmonary toxic ketene from vaping pyrolysis of vitamin E acetate. Proc Natl Acad Sci USA. 2020;117(12):6349–6355. doi: 10.1073/pnas.1920925117
- Kligerman S, Raptis C, Larsen B, et al. Radiologic, pathologic, clinical, and physiologic findings of electronic cigarette or vaping product use-associated lung injury (EVALI): Evolving knowledge and remaining questions. Radiology. 2020;294(3):491–505. doi: 10.1148/radiol.2020192585
- Hypersensitivity pneumonitis. Clinical recommendations. Russian Respiratory Society, 2022. 56 р. (In Russ).
- Henry TS, Kligerman SJ, Raptis CA, et al. Imaging findings of vaping-associated lung injury. AJR Am J Roentgenol. 2020;214(3):498–505. doi: 10.2214/AJR.19.22251
- Henry TS, Kanne JP, Kligerman SJ. Imaging of vaping-associated lung disease. N Engl J Med. 2019;381(15):1486–1487. doi: 10.1056/NEJMc1911995
- Mukhopadhyay S, Mehrad M, Dammert P, et al. Lung biopsy findings in severe pulmonary illness associated with E-cigarette use (vaping). Am J Clin Pathol. 2020;153(1):30–39. doi: 10.1093/ajcp/aqz182
- Butt YM, Smith ML, Tazelaar HD, et al. Pathology of vaping-associated lung injury. N Engl J Med. 2019;381(18):1780–1781. doi: 10.1056/NEJMc1913069
- Ghinai I, Pray IW, Navon L, et al. E-cigarette product use, or vaping, among persons with associated lung injury. MMWR. 2019;68(39):865–869. doi: 10.15585/mmwr.mm6839e2
- Mikhailovskiy AI, Voytekhovskiy VV, Luchnikova TA. Influence of liquids for electronic cigarettes on the human respiratory system. clinical observation of a patient with evali. Bull Physiol Pathol Respiration. 2022;(84):93–99. EDN: LIWNQC doi: 10.36604/1998-5029-2022-84-93-99
- Mikosz CA, Danielson M, Anderson KN, et al. Characteristics of patients experiencing re-hospitalization or death after hospital discharge in a nationwide outbreak of ecigarette, or vaping, product use-associated lung injury--United States, 2019. MMWR. 2020;68(5152):1183–1188. doi: 10.15585/mmwr.mm685152e1
- Blanchet MR, Israel-Assayag E, Cormier Y. Inhibitory effect of nicotine on experimental hypersensitivity pneumonitis in vivo and invitro. Am J Respir Crit Care Med. 2004;169(8):903–909. doi: 10.1164/rccm.200210-1154OC
- Nair N, Hurley M, Gates S, et al. Life-threatening hypersensitivity pneumonitis secondary to e-cigarettes. Arch Dis Child. 2020;105(11):1114–1116. doi: 10.1136/archdischild-2019-317889
- Sommerfeld CG, Weiner DJ, Nowalk A, Larkin A. Hypersensitivity pneumonitis and acute respiratory distress syndrome from E-cigarette use. Pediatrics. 2018;141(6):e20163927. doi: 10.1542/peds.2016-3927